Objective: The primary objective of this cross-sectional study was to examine the association between time spent treating patients with Coronavirus disease 2019 (COVID-19) and levels of depression, anxiety, and posttraumatic stress disorder (PTSD) in US physicians.
Methods: The authors conducted an anonymous online survey of US physicians. Linear regression was used to test the association between proportion of day treating COVID-19 and symptoms of depression, anxiety, and PTSD.
Results: In a sample of 1724 US physicians, proportion of day treating COVID-19 was positively and significantly associated with depression, anxiety, and PTSD scores (P < 0.001 for each).
Conclusions: Mental health resources should be provided to physicians who treat COVID-19 because the proportion of day treating COVID-19 is associated with depression, anxiety, and PTSD outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864594 | PMC |
http://dx.doi.org/10.1097/JOM.0000000000002086 | DOI Listing |
Clin Exp Optom
January 2025
2nd Department of Ophthalmology, Medical School of National and Kapodistrian University of Athens, 'Attikon' University General Hospital, Athens, Greece.
Clinical Relevance: Vitreous floaters have been associated with depressive and anxiety symptoms. However, there is a scarcity in the literature regarding the possible impact of vitreous flashes on the psychological status of the patients.
Background: Photopsias and vitreous floaters frequently co-exist.
Annu Rev Clin Psychol
January 2025
Department of Psychology, Rutgers, the State University of New Jersey, New Brunswick, New Jersey, USA; email:
Personality traits involving negative affect, as well as mental disorders including depression, anxiety, and posttraumatic stress disorder, are cardiovascular risk factors. However, which of these confer risk independently is uncertain, and the implications of their overlap, combinations, and interactions are poorly understood. Potential explanatory mechanisms are being characterized with increasing detail and sophistication.
View Article and Find Full Text PDFAm J Phys Med Rehabil
January 2025
Department of Clinical Psychology, International Institute of Behavioural Medicine, Seville, Spain.
Objective: To provide evidence that catastrophizing is the primer of the cognitive-behavioural model of fear of movement/(re)injury (FAM).
Design: A cross-sectional analysis of 180 outpatients with chronic non-specific low back pain who completed the Pain Catastrophizing Scale (PCS), the Tampa Scale of Kinesiophobia (TSK), the Roland-Morris Disability Questionnaire (RMDQ), the Hospital Anxiety and Depression Scale - Depression (HADS-D), and a pain intensity numerical rating scale (NRS). The intercorrelations of the outcome measures were estimated using Pearson's correlation coefficient (r), and regression analyses were used to examine their predictive values by following the left side of the FAM clockwise from the PCS (p = 0.
J Am Coll Health
January 2025
Department of Health Science, College of Health and Wellness, Johnson & Wales University, Providence, Rhode Island, USA.
Objective: To determine the prevalence of period poverty in university students and if experiencing period poverty is associated with poor mental health outcomes.
Methods: Participants were = 311 females assigned at birth attending a university in the northeast US. Seven items assessed period poverty.
Child Neuropsychol
January 2025
Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Persisting symptoms after concussion (PSaC) affect up to 30% of children, adolescents, and young adults beyond 1 month post-injury, posing challenges in clinical care. This retrospective study examined 54 patients referred for neuropsychological evaluation due to PSaC, exploring factors contributing to symptom persistence. Results showed that 75.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!